Hanwha Power Achieves ABS Approval for LNG Bunkering Vessel Design at GASTECH 2026 #Hanwha_Power #South_Korea #Bangkok #LNG_Bunkering #ABS_Approval
@newsen.bsky.social
@newsen.bsky.socialHanwha Power Achieves ABS Approval for LNG Bunkering Vessel Design at GASTECH 2026 #Hanwha_Power #South_Korea #Bangkok #LNG_Bunkering #ABS_Approval
@newsen.bsky.socialInnovative Functional Patches for Daily Muscle and Joint Relief Introduced by PAINSTUDY Inc. #South_Korea #Seoul #Wellness_Market #PAINSTUDY #functional_patches
@newsen.bsky.socialHanwha Power Secures Approval for 22,000 CBM LNG Bunkering Vessel Concept Design #Hanwha_Power #South_Korea #Seoul #ABS_Approval #LNG_Bunker
@newsen.bsky.socialHanwha Power Achieves ABS Certification for Next-Gen LNG Bunkering Vessel #Hanwha_Power #South_Korea #Seoul #LNG_Vessel #ABS_Certification
@newsen.bsky.socialNew Research from SEOULTECH Examines the Relationship Between YouTube Sports Engagement and Physical Activity #South_Korea #Seoul #SEOULTECH #College_Students #YouTube_Sports
@newsen.bsky.socialInnovative Nanoparticle Technology Targets H. pylori for Better Treatment of Stomach Ulcers #South_Korea #Pusan_National_University #Busan #nanotechnology #H._pylori
@newsen.bsky.socialSamsung's Health-Based Models Enhance Personalized Health Insights Through AI Technologies #South_Korea #Seoul #Samsung_Electronics #Health_AI #Biosignal
@newsen.bsky.socialPromising Results for New Lung Cancer Treatment at WCLC 2026 with RYBREVANT FASPRO and LAZCLUZE #South_Korea #Seoul #Johnson_&_Johnson #LAZCLUZE #RYBREVANT_FASPRO
@newsen.bsky.socialZipalertinib Combined with Chemotherapy Enhances Survival Rates in NSCLC Patients #South_Korea #Seoul #NSCLC #Chemotherapy #Zipalertinib
@newsen.bsky.socialLong-Term Benefits of Osimertinib in Resected EGFR-Mutated NSCLC Highlighted in ADAURA Trial Update #South_Korea #Seoul #NSCLC #Osimertinib #ADAURA
@newsen.bsky.socialGroundbreaking Phase 3 Trial Reveals Benefits of Trastuzumab Deruxtecan in HER2-Mutant Lung Cancer #South_Korea #Seoul #Trastuzumab_Deruxtecan #HER2-Mutant_NSCLC #DESTINY-Lung04
@newsen.bsky.socialYuyu Pharma Boosts Renewable Energy with New Solar Power Expansion at Manufacturing Site #South_Korea #Seoul #Renewable_Energy #Solar_Power #Yuyu_Pharma
@newsen.bsky.socialNEXTBIOMEDICAL Showcases Innovative Solutions at CIRSE 2026: A Landmark Presence in Interventional Radiology #South_Korea #Seoul #Nexsphere-F #Nexsphere #CIRSE
@newsen.bsky.socialBiodance's New Hydrogel Mask Study Validates Skin Recovery After Laser Treatment #South_Korea #Seoul #Hydrogel_Mask #Biodance #Skin_Recovery
@newsen.bsky.socialAdvancements in Lithium-Metal Battery Technology from Hanbat University Researchers #South_Korea #Daejeon #battery_technology #lithium-metal #Hanbat_University
@newsen.bsky.socialStudy Reveals Plasma p-Tau217 as a Tracker for Lecanemab Response in Early Alzheimer's #South_Korea #Seoul #Korea_University #Lecanemab #p-Tau217
@newsen.bsky.socialZidesamtinib Shows Promising Results in ROS1-Positive NSCLC Patients #South_Korea #Seoul #NSCLC #zidesamtinib #ROS1-positive
@newsen.bsky.socialJohnson & Johnson’s RYBREVANT Plus Chemo Pioneers Survival Gains in Lung Cancer #South_Korea #Seoul #Lung_Cancer #RYBREVANT #EGFR
@newsen.bsky.socialLatest MAVERICK Trial Results Favor MRI Surveillance for Small-Cell Lung Cancer Management without Irradiation #South_Korea #Seoul #SCLC #MAVERICK #MRI_Surveillance
@newsen.bsky.socialLatest Phase III Trial: Tam-Peli Offers Hope for Small-Cell Lung Cancer Patients #South_Korea #Seoul #SCLC #Tam-Peli #TAISHAN-302